(VIANEWS) – AMSC (AMSC.OL), MAGNORA (MGN.OL), PANORO ENERGY (PEN.OL) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. AMSC (AMSC.OL)
1395% sales growth and 8.21% return on equity
AMSC ASA, through its subsidiaries, operates as a ship owning and lease finance company in the United States. The company purchases and bareboat charters out vessels to operators and end users. It operates a fleet of nine product tankers, one shuttle tanker, and one subsea construction vessel. The company was formerly known as American Shipping Company ASA and changed its name to AMSC ASA in October 2022. AMSC ASA was founded in 2005 and is headquartered in Lysaker, Norway.
Earnings Per Share
As for profitability, AMSC has a trailing twelve months EPS of kr4.32.
PE Ratio
AMSC has a trailing twelve months price to earnings ratio of 6.15. Meaning, the purchaser of the share is investing kr6.15 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.21%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 75.8% and 46.8%, respectively.
Earnings Before Interest, Taxes, Depreciation, and Amortization
AMSC’s EBITDA is 465.79.
Revenue Growth
Year-on-year quarterly revenue growth grew by 39.6%, now sitting on 102.25M for the twelve trailing months.
Volume
Today’s last reported volume for AMSC is 38496 which is 65.47% below its average volume of 111507.
More news about AMSC.
2. MAGNORA (MGN.OL)
210.1% sales growth and 52.28% return on equity
Magnora ASA operates as a renewable energy development company. It primarily focuses on developing wind and solar photovoltaic (PV) projects. The company also hold license agreements with the Dana Western Isles and Shell Penguins FPSO. It serves oil companies and marine contractors in the United Kingdom, Norway, and Sweden. The company was formerly known as Sevan Marine ASA and changed its name to Magnora ASA in October 2018. Magnora ASA was incorporated in 2001 and is based in Oslo, Norway.
Earnings Per Share
As for profitability, MAGNORA has a trailing twelve months EPS of kr3.95.
PE Ratio
MAGNORA has a trailing twelve months price to earnings ratio of 7.49. Meaning, the purchaser of the share is investing kr7.49 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 52.28%.
More news about MAGNORA.
3. PANORO ENERGY (PEN.OL)
73.9% sales growth and 15.08% return on equity
Panoro Energy ASA, an independent exploration and production company, engages in the exploration, development, and production of oil and gas properties in Africa. It holds assets in the Equatorial Guinea, Gabon, Tunisia, and South Africa. The company was incorporated in 2009 and is based in London, the United Kingdom.
Earnings Per Share
As for profitability, PANORO ENERGY has a trailing twelve months EPS of kr3.16.
PE Ratio
PANORO ENERGY has a trailing twelve months price to earnings ratio of 8.13. Meaning, the purchaser of the share is investing kr8.13 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.08%.
Moving Average
PANORO ENERGY’s value is below its 50-day moving average of kr26.14 and under its 200-day moving average of kr28.15.
Revenue Growth
Year-on-year quarterly revenue growth declined by 22.1%, now sitting on 228.87M for the twelve trailing months.
Earnings Before Interest, Taxes, Depreciation, and Amortization
PANORO ENERGY’s EBITDA is 64.9.
More news about PANORO ENERGY.
4. J.MARTINS,SGPS (JMT.LS)
17.7% sales growth and 28.68% return on equity
Jerónimo Martins, SGPS, S.A. operates in the food distribution and specialized retail sectors in Portugal, Poland, and Colombia. The company operates through Portugal Retail; Portugal Cash & Carry; Poland Retail; Colombia Retail; and Others, Eliminations and Adjustments segments. It operates food stores under the Biedronka name; and a chain of health and beauty stores under the Hebe banner in Poland, as well as food stores under the Ara name in Colombia. The company also operates supermarkets under the Pingo Doce banner; and cash and carry stores under the Recheio name in Portugal. In addition, it operates restaurants under the Pingo Doce name; Bem-Estar pharmacies; petrol stations; and clothing under Code brand. Further, the company operates kiosks and coffee shops under the Jeronymo name; and chocolates and confectionary retail stores under Hussel name. Additionally, the company engages in human resources top management, real estate management and administration, training, and saline brackish waters aquaculture; wholesale of fruit and vegetables; retail management, consultancy, and logistics activities; the purchase and sale of real estate; growing of crops and farming of animals; retail sale of health and beauty products; manufacture of milk and dairy products; and provision of economic and accounting, business portfolio management, financial, and sea passenger water transport services. It is also involved in the trading and distribution of consumer goods; retail and wholesale of non-food products; other business support service activities; and provision of services in the area of wholesale and retail distribution. The company was founded in 1792 and is headquartered in Lisbon, Portugal. Jerónimo Martins, SGPS, S.A. operates as a subsidiary of Sociedade Francisco Manuel Dos Santos, S.G.P.S., S.A.
Earnings Per Share
As for profitability, J.MARTINS,SGPS has a trailing twelve months EPS of €1.16.
PE Ratio
J.MARTINS,SGPS has a trailing twelve months price to earnings ratio of 19. Meaning, the purchaser of the share is investing €19 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 28.68%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
J.MARTINS,SGPS’s EBITDA is 33.41.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 13.8% and 29.6%, respectively.
Yearly Top and Bottom Value
J.MARTINS,SGPS’s stock is valued at €22.04 at 16:20 EST, way below its 52-week high of €27.10 and way higher than its 52-week low of €18.30.
Volume
Today’s last reported volume for J.MARTINS,SGPS is 180788 which is 68.72% below its average volume of 577980.
More news about J.MARTINS,SGPS.
5. HOLLAND COLOURS (HOLCO.AS)
13.8% sales growth and 6.75% return on equity
Holland Colours N.V., together with its subsidiaries, manufactures, distributes, and sells color concentrates in Europe, the Middle East, India, Africa, the Americas, and Asia. The company offers colorants for the building and construction industry, including profiles, pipes, tubing and fittings, siding and cladding, decking, fencing, window blinds, and insulation, as well as solutions for a range of polymers. It also provides colorants for packaging applications comprising water, carbonated soft drinks, fruit juices, dairy, beer, wine, detergents, pharmaceutical, and personal care products. In addition, the company offers coatings, sealants, or adhesives; and colorants for other markets, such as shopping bags, polybags, mulch films, OPP tapes, PU flexible foams, synthetic leather, fiber glass and buttons, paving blocks, artificial stones, cast PMMA, PP non-woven and spunbond, coatings, flexible PVCs, prosthetics, glass fiber reinforced nylon, and silicone rubber and elastomers. It sells its products through a network of agents and distributors. The company was founded in 1979 and is headquartered in Apeldoorn, the Netherlands. Holland Colours N.V. is a subsidiary of Holland Pigments BV.
Earnings Per Share
As for profitability, HOLLAND COLOURS has a trailing twelve months EPS of €4.68.
PE Ratio
HOLLAND COLOURS has a trailing twelve months price to earnings ratio of 18.8. Meaning, the purchaser of the share is investing €18.8 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.75%.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Jul 17, 2023, the estimated forward annual dividend rate is 3.41 and the estimated forward annual dividend yield is 3.99%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 17%, now sitting on 100.74M for the twelve trailing months.
Yearly Top and Bottom Value
HOLLAND COLOURS’s stock is valued at €88.00 at 16:20 EST, way under its 52-week high of €124.00 and higher than its 52-week low of €82.00.
Sales Growth
HOLLAND COLOURS’s sales growth is 13.8% for the current quarter and 13.8% for the next.
More news about HOLLAND COLOURS.
6. NEURONES (NRO.PA)
10.5% sales growth and 15.36% return on equity
Neurones S.A., an information technology (IT) services company, provides infrastructure, application, and consulting services in France and internationally. Its infrastructure services include infrastructure management, manages public and private cloud services, IT operations, user support, DevOps, cybersecurity, IT service management, information system governance, and automation. The company also provides application services in the areas of SAP, digital, WEB, mobility, UX/UI, enterprise content and document management, business process management, robotic process automation, dematerialization, IT consulting for finance, big data, and DevOps, IT training and change management, and Innovation connected devices (IOT). In addition, it offers consulting services, including management and digital transformation, and digital marketing consulting; digital transformation services in the areas of agile/scrum, DevOps, CI/CD, cloud, infrastructure as code, cyber security, analytics, big data, mobility, digital workplace, connected devices, innovations, client experience, UX/UI, and digital marketing, as well as internal process digitization, ECM/BPM, RPA, dematerialization, AI, predictive maintenance, machine learning, and blockchain; and managed services/outsourcing services. The company serves banking/insurance, services/consumer goods, energy/utilities/healthcare, technologies/media/telecoms, industry/public works and civil engineering, and public sector markets. Neurones S.A. was founded in 1984 and is based in Nanterre, France.
Earnings Per Share
As for profitability, NEURONES has a trailing twelve months EPS of €1.96.
PE Ratio
NEURONES has a trailing twelve months price to earnings ratio of 23.42. Meaning, the purchaser of the share is investing €23.42 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.36%.
Yearly Top and Bottom Value
NEURONES’s stock is valued at €45.90 at 16:20 EST, below its 52-week high of €46.35 and way higher than its 52-week low of €33.45.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Jun 14, 2023, the estimated forward annual dividend rate is 1.1 and the estimated forward annual dividend yield is 2.49%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 12.7%, now sitting on 706.93M for the twelve trailing months.
Sales Growth
NEURONES’s sales growth is 10.5% for the present quarter and 10.5% for the next.
More news about NEURONES.
7. VISTIN PHARMA (VISTN.OL)
6.6% sales growth and 16.03% return on equity
Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, produces and sells active pharmaceutical ingredients (APIs) worldwide. It offers metformin HCl APIs and direct compressive granulates for the pharmaceutical industry. The company was founded in 1969 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, VISTIN PHARMA has a trailing twelve months EPS of kr1.
PE Ratio
VISTIN PHARMA has a trailing twelve months price to earnings ratio of 22.6. Meaning, the purchaser of the share is investing kr22.6 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.03%.
Volume
Today’s last reported volume for VISTIN PHARMA is 4472 which is 68.5% below its average volume of 14201.
Sales Growth
VISTIN PHARMA’s sales growth is 10.6% for the present quarter and 6.6% for the next.
Moving Average
VISTIN PHARMA’s value is below its 50-day moving average of kr23.13 and below its 200-day moving average of kr23.02.
More news about VISTIN PHARMA.
